Flubrotizolam

Flubrotizolam is a benzodiazepine derivative which was first synthesized in 1975, but was never marketed. It has been sold online as a designer drug.

Chemistry[edit | edit source]

Flubrotizolam is a structural analogue of benzodiazepine. It is classified as a central nervous system (CNS) depressant, and belongs to a class of drugs known as thienodiazepines, which are bioisosteres to benzodiazepines.

Pharmacology[edit | edit source]

Flubrotizolam acts as a high-potency ultra-long-lasting benzodiazepine receptor agonist. It has been found to produce a variety of effects by binding to the benzodiazepine receptor site and magnifying the efficiency and effects of the neurotransmitter gamma aminobutyric acid (GABA) by acting on its receptors.

Effects[edit | edit source]

The effects of Flubrotizolam include sedation, muscle relaxation, reduction in anxiety, and prevention of seizures. It has a high addictive potential and should be used with caution.

Legal Status[edit | edit source]

The legal status of Flubrotizolam varies by country. In some countries, it is legal for research purposes but not for human consumption.

References[edit | edit source]

This pharmacology-related article is a stub. You can help WikiMD by expanding it.

‎

Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Search WikiMD

Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro) available.
Advertise on WikiMD

WikiMD is not a substitute for professional medical advice. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.